Table 1.
Baseline demographic and clinical characteristics in patients with IPMN with/without AP
| IPMN | P-value | ||
|---|---|---|---|
| AP (n = 11) | Non-AP (n = 36) | ||
| Demography | |||
| Age | 62.0 (52.0–72.0) | 64.5 (57.5–69.5) | 0.555 |
| Sex | 0.461 | ||
| Male | 9 (81.8) | 23 (63.9) | |
| Female | 2 (18.2) | 13 (36.1) | |
| Smoking | 1 (9.1) | 17 (47.2) | 0.033 |
| Alcohol consumption | 0 (0) | 4 (11.1) | 0.560 |
| Hypertension | 1 (9.1) | 16 (44.4) | 0.039 |
| Diabetes | 1 (9.1) | 8 (22.2) | 0.663 |
| Family History | |||
| AP | 0 (0) | 0 (0) | |
| Pancreatic tumors | 0 (0) | 0 (0) | |
| AP occurrence times | |||
| 1 | 8 (72.7) | ||
| 2 | 1 (9.1) | ||
| 3 | 2 (18.2) | ||
| Laboratory results | |||
| Total bilirubin (µmol/L) | 11.8 (8.2–14.8) | 14.3 (10.3–42.2) | 0.158 |
| CEA (ng/ml) | 1.5 (1.2–3.2) | 2.5 (1.5–4.4) | 0.299 |
| CA199 (ng/ml) | 15.3 (7.3–29.5) | 12.9 (8.9–44.7) | 0.915 |
AP: acute pancreatitis; CA: carbohydrate antigen; CEA: carcinoembryonic antigen; IPMN: intraductal papillary mucinous neoplasms
Significant values are shown in bold.Continuous data are presented as median (Q1-Q3) and categorical data are presented as n (%)